2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Afluria: new trials by email Literature Review of Afluria trials Research Report on Afluria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age Flublok, Afluria - Influenza | Phase 3 | Completed | Protein Sciences Corporation | 2640 | 2013-03-01 | 2015-02-18 |
| A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population CSL's Influenza Virus Vaccine (Afluria), Influenza Virus Vaccine (Fluzone) - Influenza | Phase 3 | Completed | Seqirus | 1474 | 2009-09-01 | 2017-05-16 |
Influenza, Human (2)
Protein Sciences Corporation (1) · Seqirus (1)
United States (2)
Alan C. Wine, MD (1) · Bob Weiss, MD (1) · Brandon Essink, MD (1) · Darrell Herrington, DO (1) · Eric Sheldon (1) · Frank Eder, MD (1) · George Bauer, MD (1) · Jeffrey Rosen, MD (1) · Joe Blumenau, MD (1) · Leah Schmidt, DO (1) · Paul Bradley, MD (1) · Steven Folkerth, MD (1) · Terry Poling, MD (1) · Treva Tyson, MD (1)